| AEMPS | Spanish Agency of Medicines and Medical Devices (Agencia Española de Medicamentos y Productos Sanitarios) |
| AMNOG | German Act on the Reform of the Market for Medicinal Products (Arzneimittelmarktneuordnungsgesetz) |
| ASMR | Improvement in the actual benefit |
| ATMP | Advanced therapy medicinal products |
| EMA | European Medicines Agency |
| EU | European Union |
| G-BA | German Federal Joint Committee (Gemeinsamer Bundesausschuss) |
| HTA | Health Technology Assessment |
| HTDs | Health Technology Developers |
| ITC | Indirect treatment comparison |
| JCA | Joint Clinical Assessment |
| MAIC | Matching-adjusted indirect comparison |
| MS | Member States |
| PICO | Population, Intervention, Comparator, Outcomes |
| RCT | Randomised control trial |
| RE | Relative effectiveness |
| RoB | Risk of Bias |
| SATs | Single-arm trials |
| SMR | Rating of actual benefit |
| TLI | Drug technologies with a high level of innovation |
| TLK | Drug technologies with high clinical value |